Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activities
Growth Metrics
Income Statement
Others
Ratios

Acro Biomedical (ACBM) Change in Cash (2016 - 2025)

Acro Biomedical (ACBM) has 10 years of Change in Cash data on record, last reported at -$225.0 in Q4 2025.

  • For Q4 2025, Change in Cash changed 0.0% year-over-year to -$225.0; the TTM value through Dec 2025 reached $3622.0, up 3522.0%, while the annual FY2025 figure was $3622.0, 3522.0% up from the prior year.
  • Change in Cash reached -$225.0 in Q4 2025 per ACBM's latest filing, down from $4297.0 in the prior quarter.
  • Across five years, Change in Cash topped out at $262420.0 in Q1 2022 and bottomed at -$345561.0 in Q2 2022.
  • Average Change in Cash over 5 years is -$701.25, with a median of -$225.0 recorded in 2024.
  • Peak YoY movement for Change in Cash: plummeted 26936.0% in 2021, then skyrocketed 4108.15% in 2022.
  • A 5-year view of Change in Cash shows it stood at -$59415.0 in 2021, then skyrocketed by 82.6% to -$10336.0 in 2022, then soared by 71.99% to -$2895.0 in 2023, then skyrocketed by 92.23% to -$225.0 in 2024, then changed by 0.0% to -$225.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Cash were -$225.0 in Q4 2025, $4297.0 in Q3 2025, and -$225.0 in Q2 2025.